XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Condensed Statements Of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jan. 31, 2022
Jan. 31, 2021
Cash flows from operating activities:    
Net income (loss) $ 91,409 $ (7,891)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 123,559 125,291
Stock-based compensation expense 12,904 12,333
Deferred income taxes, net 9,214 (8,779)
Change in Fair Value of Contingent Consideration 18,780 1,802
Other non-cash income, net (602) (1,698)
Changes in assets and liabilities:    
Trade receivables, net 178,252 (9,014)
Inventories, net (23,627) 16,151
Accounts payable and accrued liabilities 89,502 111,481
Deferred revenue 147,614 220,846
Income taxes payable - excess tax benefit from share award exercises (17,018) (1,478)
Income taxes payable - other (7,581) (2,454)
Other assets and liabilities, net (11,077) 2,479
Net cash provided by operating activities 611,329 459,069
Cash flows from investing activities:    
Capital expenditures (128,854) (67,338)
Payments to Acquire Businesses, Net of Cash Acquired 118,099 0
Other investing activities, net 21,421 1,608
Net cash used in investing activities (225,532) (65,730)
Cash flows from financing activities:    
Proceeds from borrowings under Whistler Credit Agreement 0 21,144
Proceeds from Convertible Debt 0 575,000
Repayments of borrowings under Vail Holdings Credit Agreement (31,250) (31,250)
Repayments of borrowings under Whistler Credit Agreement (23,145) (22,380)
Repayments of Long-term Debt (51,500) 0
Employee taxes paid for share award exercises (37,302) (7,534)
Dividends paid (71,338) 0
Other financing activities, net (6,158) (21,693)
Net cash (used in) provided by financing activities (220,693) 513,287
Effect of exchange rate changes on cash, cash equivalents and restricted cash (1,016) 3,292
Net increase in cash, cash equivalents and restricted cash 164,088 909,918
Cash, cash equivalents and restricted cash:    
Beginning of period 1,258,574 402,086
End of period 1,422,662 1,312,004
Accrued capital expenditures $ 17,388 $ 12,877